To further verify the effect of FNDC5 on the levels of Nrf2 via the PI3K/Akt pathway, we treated HCC sorafenib-resistant cells with a PI3K inhibitor for 1 h, and then added sorafenib to detect the levels of Nrf2 and ferroptosis marker proteins. Here, AKT1 is linked to hepatocellular carcinoma.